Imogene Dunn
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
Papers in
-
- Diabetes Management and Research 2
- Natural Antidiabetic Agents Studies 2
-
- Advanced Glycation End Products research 5
- Co-authors
- Carmen Valcarce (7 shared papers)Aaron H. Burstein (6 shared papers)Marwan N. Sabbagh (2 shared papers)L. Altstiel (1 shared paper)John B. Buse (3 shared papers)Kit A. Keller (1 shared paper)Adrian Vella (1 shared paper)Yong Joong Kim (2 shared papers)
- Journals
- Alzheimer s & Dementia (4 papers)Diabetes (2 papers)Therapeutic Innovation & Regulatory Science (2 papers)Science Translational Medicine (1 paper)Diabetes Obesity and Metabolism (1 paper)
- Partner nations
- United StatesAustraliaRussia
In The Last Decade
Imogene Dunn
14 papers receiving 228 citations
Peers
Comparison fields: 5 of 60
- Clinical Biochemistry 61
- Biological Psychiatry 11
- Endocrinology, Diabetes and Metabolism 63
- Neurology 30
- Physiology 81
Countries citing papers authored by Imogene Dunn
This map shows the geographic impact of Imogene Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imogene Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imogene Dunn more than expected).
Fields of papers citing papers by Imogene Dunn
This network shows the impact of papers produced by Imogene Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imogene Dunn. The network helps show where Imogene Dunn may publish in the future.
Co-authors
The 25 scholars most cited alongside Imogene Dunn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 118 | |
| 2 | 2019 | 49 | |
| 3 | 2015 | 17 | |
| 4 | 2015 | 15 | |
| 5 | 1958 | 8 | |
| 6 | 2022 | 7 | |
| 7 | 2019 | 5 | |
| 8 | 2019 | 4 | |
| 9 | 2020 | 4 | |
| 10 | 2016 | 4 | |
| 11 | 2019 | 4 | |
| 12 | Query Effectiveness in Light of Risk-Based Monitoring (RBM) | 2018 | 1 |
| 13 | 2018 | 1 | |
| 14 | 2017 | 1 | |
| 15 | 2024 | 0 |
About Imogene Dunn
Imogene Dunn is a scholar working on Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Physiology, Surgery and Molecular Biology, having authored 15 papers that have together received 238 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (5 papers), Alzheimer's disease research and treatments (4 papers), Pancreatic function and diabetes (3 papers), Blood Pressure and Hypertension Studies (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Diabetes Management and Research (2 papers), Natural Antidiabetic Agents Studies (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). The work is most often cited by research in Clinical Biochemistry (61 citations), Biological Psychiatry (11 citations), Endocrinology, Diabetes and Metabolism (63 citations), Neurology (30 citations) and Physiology (81 citations). Imogene Dunn has collaborated with scholars based in United States, Australia and Russia. Frequent co-authors include Carmen Valcarce, Aaron H. Burstein, Marwan N. Sabbagh, L. Altstiel, John B. Buse, Kit A. Keller, Adrian Vella, Yong Joong Kim, Jules T. Mitchel and Irwin M. Weinstein. Their work appears in journals such as Alzheimer s & Dementia, Diabetes, Therapeutic Innovation & Regulatory Science, Science Translational Medicine and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.